Cargando…

Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.

The survival time of mice after i.v. injection of the cancerostatic lectins, abrin and ricin was recorded. The LD50 dose was found to be 10-13 ng and 55-65 ng per mouse for abrin and ricin, respectively. Increasing amounts of toxin reduced the survival time, reaching a minimum of about 10 h. Lactose...

Descripción completa

Detalles Bibliográficos
Autores principales: Fodstad, O., Olsnes, S., Pihl, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1976
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025264/
https://www.ncbi.nlm.nih.gov/pubmed/974006
_version_ 1782136729321340928
author Fodstad, O.
Olsnes, S.
Pihl, A.
author_facet Fodstad, O.
Olsnes, S.
Pihl, A.
author_sort Fodstad, O.
collection PubMed
description The survival time of mice after i.v. injection of the cancerostatic lectins, abrin and ricin was recorded. The LD50 dose was found to be 10-13 ng and 55-65 ng per mouse for abrin and ricin, respectively. Increasing amounts of toxin reduced the survival time, reaching a minimum of about 10 h. Lactose injected with ricin, provided partial protection against ricin, as measured by the survival time. Abrin and ricin labelled with 125I, and shown to retain their full toxic activity, were injected into mice. Most of the radioactivity found in the organs was present in the form of intact toxins, at least up to 5 h after injection. After i.v. injection the highest concentration/g tissue was found in spleen, followed by kidneys, heart, liver and thymus. The relative concentration in liver was considerably higher for ricin than for abrin. Similar results were found after i.p. injection. When lactose was administered together with ricin, almost 80% of the ricin injected was found in the liver after 30 min, compared to 48% without lactose, and the amount in other organs was concurrently reduced. The elimination of total radioactivity was much faster for ricin than abrin. The radioactivity found in the urine was largely present in non-trichloroacetic acid precipitable form, indicating that the toxins were extensively degraded before excretion.
format Text
id pubmed-2025264
institution National Center for Biotechnology Information
language English
publishDate 1976
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20252642009-09-10 Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice. Fodstad, O. Olsnes, S. Pihl, A. Br J Cancer Research Article The survival time of mice after i.v. injection of the cancerostatic lectins, abrin and ricin was recorded. The LD50 dose was found to be 10-13 ng and 55-65 ng per mouse for abrin and ricin, respectively. Increasing amounts of toxin reduced the survival time, reaching a minimum of about 10 h. Lactose injected with ricin, provided partial protection against ricin, as measured by the survival time. Abrin and ricin labelled with 125I, and shown to retain their full toxic activity, were injected into mice. Most of the radioactivity found in the organs was present in the form of intact toxins, at least up to 5 h after injection. After i.v. injection the highest concentration/g tissue was found in spleen, followed by kidneys, heart, liver and thymus. The relative concentration in liver was considerably higher for ricin than for abrin. Similar results were found after i.p. injection. When lactose was administered together with ricin, almost 80% of the ricin injected was found in the liver after 30 min, compared to 48% without lactose, and the amount in other organs was concurrently reduced. The elimination of total radioactivity was much faster for ricin than abrin. The radioactivity found in the urine was largely present in non-trichloroacetic acid precipitable form, indicating that the toxins were extensively degraded before excretion. Nature Publishing Group 1976-10 /pmc/articles/PMC2025264/ /pubmed/974006 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Fodstad, O.
Olsnes, S.
Pihl, A.
Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
title Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
title_full Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
title_fullStr Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
title_full_unstemmed Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
title_short Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
title_sort toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025264/
https://www.ncbi.nlm.nih.gov/pubmed/974006
work_keys_str_mv AT fodstado toxicitydistributionandeliminationofthecancerostaticlectinsabrinandricinafterparenteralinjectionintomice
AT olsness toxicitydistributionandeliminationofthecancerostaticlectinsabrinandricinafterparenteralinjectionintomice
AT pihla toxicitydistributionandeliminationofthecancerostaticlectinsabrinandricinafterparenteralinjectionintomice